conditions such as obscure GI tract bleeding, inflammatory bowel disease, small bowel neoplastic lesions and
Crohn’s disease. On the other hand, colon capsule segment is anticipated to exhibit strong development over
the forecast period. According to CDC, each year 608,000 fatalities are caused by colorectal cancer. Every year
more than 14.5 million colonoscopies are performed. Moreover, rising demand for less invasive diagnosis
platform is a key factor assuring the aforementioned conclusion.
Accessories Insights
In 2016, wireless capsule held the leading position amongst the various application segments. The expanding
utilization rate of wireless capsules in the colon, esophagus and small intestine and the presence of conducive
reimbursement policies are some major drivers for this segment. Technologically enhanced capsules with inbuilt
components, such as 360-degree panoramic view, easy transmission, enhanced data storage capability, larger
frame rate and greater battery life are further providing this segment with lucrative growth opportunities.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/capsule-endoscopy-market
Application Insights
Leading application segments in 2016 was oscure gastrointestinal bleeding (OGIB). As per the research study of
the U.S. National Library of Medicine, CE was found to be more effective as compared to barium X-rays used for
examination of OGIB. This technique is utilized for diagnosis of occult bleeding in the duodenum and also for
the diagnosis of small bowel tumors and Crohn’s disease. Furthermore, additional advantages such as faster and
easier diagnosis and real-time visualization of the whole small intestine, patients and healthcare professionals,
are moving their inclination from conventional methods (i.e. double balloon enteroscopy) to CE. This fact is
projected to establish healthy platform for the development of this segment over the forecast period. Crohn’s
disease application market is expected to experience significant growth because of increasing prevalence this
disease together with adoption of CE technique as preferred diagnosis method.
Regional Insights
The largest regional market in 2016 was North America. Rising incidence of colorectal cancer & GI disorders
combined with enhanced healthcare infrastructure, presence of conducive reimbursement policies and growing
adoption of invasive capsule endoscopy are a few components estimated to drive regional market growth. Asia-
Pacific market is considered to grow at a highest growth rate due to rising patient awareness levels, disposable
income, advancing healthcare infrastructure and huge presence of untapped opportunities pertaining to cancer
screening.